---
title: "KORU Medical Systems signs agreement for subcutaneous immunoglobulin infusion system"
date: "2025-02-07 16:50:51"
summary: "KORU Medical Systems (NASDAQ:KRMD) announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin therapy infusion system for use with a commercialized drug therapy. Additionally, the project will include a close..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* KORU Medical Systems (NASDAQ:[KRMD](https://seekingalpha.com/symbol/KRMD "KORU Medical Systems, Inc.")) announced the signing of an agreement with a global pharmaceutical company.
* The agreement is intended for KORU Medical to develop and seek regulatory clearance for a next-generation subcutaneous immunoglobulin therapy infusion system for use with a commercialized drug therapy.
* Additionally, the project will include a close collaboration with SCHOTT Pharma and is expected to be the first of multiple joint projects with SCHOTT, allowing KORU Medical to develop a platform infusion system that can integrate with both a vial and prefilled syringe.
* Source: [Press Release](https://seekingalpha.com/pr/19994978-koru-medical-systems-announces-agreement-for-next-generation-subcutaneous-immunoglobulin)

[seekalpha](https://seekingalpha.com/news/4405131-koru-medical-systems-signs-agreement-for-subcutaneous-immunoglobulin-infusion-system)
